Tolerance and Pharmacokinetics of TQ-B3233
Clinical trial NCT03453034 · UNKNOWN
Trial details
- NCT number
- NCT03453034
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-22
- Primary completion
- 2018-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.